Physician profile
Mohammad Mannan
NPI 1588741904
$892.62
in general payments reported to CMS, 2019-2025
17 companies · $80.26 in 2025
The $80.26 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.65 · 2020: $257 · 2021: $187 · 2022: $36.69 · 2023: $138 · 2024: $98.41 · 2025: $80.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $343.81 | 2019-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.06 | 2019-2021 | |
| Lilly USA, LLC | $84.53 | 2023-2025 | Mounjaro |
| Mallinckrodt Hospital Products INC. | $54.65 | 2020 | |
| Dexcom, INC. | $49.56 | 2024-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.16 | 2024-2025 | Xifaxan |
| Circassia INC. | $30.08 | 2019-2020 | |
| Mylan Specialty L.P. | $22.71 | 2021 | |
| Axsome Therapeutics, INC. | $19.45 | 2023 | Auvelity |
| Novo Nordisk INC | $19.29 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $19.17 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.33 | 2020 | |
| Exact Sciences Corporation | $18.10 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $17.00 | 2024 | |
| Mallinckrodt Enterprises LLC | $14.46 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $12.87 | 2019 | |
| Philips North America LLC | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Mannan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.